Lannett Company (LCI) announced on September 27 that is had received FDA approval for a new drug. The Oxycodone and Acetaminophin tablets USP, 5 mg/325 mg and 10 mg/325 mg are the therapeutic equivalent to the drug Percocet. U.S. sales of Oxycodone and Acetaminophin tablets USP, 5 mg/325 mg and 10 mg/325 mg totaled around […]
On September 20, Phoenix Color Corp, a wholly owned subsidiary of ALJ Regional Holdings, entered into an asset purchase agreement with LSC Communications and Moore-Langen Printing. In the agreement, ALJ will obtain printing and manufacturing facilities in Terre Haute, Indiana. Sonal sent a level 3 alert to its subscribers at 7:01 am on September […]
Sage Therapeutics announced disappointing results on its late-stage clinical trial of a brexanolone treament for a seizure disorder called super-refractory status epilepticus (SRSE). Right now there is no U.S. drug approved for the condition. Sonal caught the news at 6:15 am with a level 2 alert before the stock price fell from $88.22 to $74.65. […]
On September 20, Halcon Resources (HK) announced plans to divest its remaining non-operated oil assets in the Williston Basin to an undisclosed company for $104 million. Halcon started selling assets in the Williston Basin earlier this year in order to pay down its debt and focus on its operations in the Delaware Basin. Sonal […]
Alnylam Pharmaceuticals reported exciting stage 3 clinical trial results on September 20. Its drug, patisiran, treats a rare nerve disorder called familial amyloid polyneuropathy. Alnylam will seek regulatory approval for patisiran later this year. Sonal sent out a level 2 alert at 7 am, and the next trade was at $93.50 during pre-market trading. […]
PDL BioPharma (PDLI) announced on September 25 that its board of directors authorized a new stock repurchase program. PDL will be able to purchase up to $25 million worth of its common stock. The company has a market cap of $500 million, so this repurchase amounts to about 5% of the total outstanding shares. […]
On September 18, Wabco Holdings (WBC) announced its plans to buyout its joint venture partner, Meritor, Inc. WBC is a commercial vehicle supplier and believes this move will allow the company to expand its presence in the North American market. Sonal sent out a level 3 alert at 6:30 am to its subscribers. The […]
On September 15, The Stars Group provided updated guidance for the year that included revenue growth of between 11 and 14% over last year. The company also announced its plan to prepay a $75 million second lien debt. The news triggered a level 3 Sonal alert at 6:31 am, and the next trade was […]
What are clinical trials? Pharmaceutical or bio-medical companies that have new drugs or medical products need to have those new products tested before they can be released in the market. The public needs assurance that these new products are both safe and effective. The process is called a clinical trial and involves many steps. Clinical […]
Event Based Trading: A Daily Opportunity for Profit Event-based trading involves trading based on market events and announcements that can create movements in a stock price. Volatility tends to increase during these times, so traders have a better opportunity to generate higher trading profits. Even after the event occurs, residual volatility can remain for days […]
What is M&A Arbitrage? Mergers and Acquisitions (M&A) occur when one company buys another company. Whether the purchase is considered a merger or acquisition is related to the size of each company and the way in which the businesses will exist after the M&A activity. Mergers are usually two companies of around the same size, […]
Let us send you a summary of the signals Sonal generates EVERY WEEK… and you can decide if you’re missing anything.